Ankur Drugs & Pharma Ltd.
BSE: 531683 | Sector: Health care |
NSE: ANKURDRUGS | ISIN Code: INE238D01012 |
BSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd is not traded on BSE in the last 30 days |
NSE 05:30 | 01 Jan | Ankur Drugs & Pharma Ltd Not listed in NSE |
About Ankur Drugs & Pharma Ltd.
Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of pharmaceuticals formulations. The company has three manufacturing units: two in Himachal Pradesh and one in Daman. Its business segment includes pharmaceutical formulations in the form of tablets capsules liquid orals oral powder dry syrups ointments insta use suspension form fill and seal (FFS) liquid injectables and dry powder in...> More
Announcement
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Ankur Drugs & Pharma Ltd - Financial Results
Particulars (![]() |
Dec 2012 | Dec 2011 | % Chg |
Net Sales | 36.12 | 38.5 | -6.18 |
Other Income | 0.01 | 0.01 | 0 |
Total Income | 36.13 | 38.51 | -6.18 |
Total Expenses | 37.64 | 45.92 | -18.03 |
Operating Profit | -1.51 | -7.41 | 79.62 |
Net Profit | -40.84 | -36.62 | -11.52 |
Equity Capital | 19.34 | 19.34 | - |
Ankur Drugs & Pharma Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Beryl Drugs | 9.00 | -2.70 | 4.56 |
Hind.Bio Science | 3.91 | 2.62 | 4.01 |
Bacil Pharma | 4.57 | 4.82 | 2.69 |
Ankur Drugs & Pharma Ltd - SHAREHOLDING PATTERN
|
|
Ankur Drugs & Pharma Ltd - STOCK STRENGTH
YEAR Low/High | 0.00 | 0.00 | |
All TIME Low/High | 1.75 | 487.00 |
Quick Links for Ankur Drugs & Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices